Back to Ovarian Cancer
NCT01540747
NCT01540747
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with Polycystic Ovary Syndrome (PCOS), a hormonal condition affecting the ovaries
- Your menstrual cycle is irregular, lasting longer than 28-30 days
- Your uterus has been found to be normal in shape and structure
- Your Body Mass Index (BMI) — a measure of body weight relative to height — is between 20 and 26
- This would be your first time undergoing IVF (in vitro fertilisation) treatment
Who may not be able to join:
- Your infertility has been found to be caused by problems with the fallopian tubes, the uterus, genetics, or your partner's sperm
- You have been diagnosed with cancer
- You have received any hormone-based treatment within the last six months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 4: approximately Approved of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 4
Sponsor
AGUNCO Obstetrics and Gynecology Centre
Registry
clinicaltrials_gov
Where this trial is recruiting
🇮🇹 Italy
Primary endpoints
Number of mature oocytes; embryo quality; Pregnancy rate; Implantation rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.